CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

News > Business News

Audio By Carbonatix

4:05 AM on Wednesday, December 18, 2024

The Associated Press

BRISBANE, Calif.--(BUSINESS WIRE)--Dec 18, 2024--

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that the company will participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

CareDx’s management is scheduled to present on Tuesday, January 14, 2025, at 4:30 p.m. Pacific Time (7:30 p.m Eastern Time). To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241218036532/en/

CONTACT: CareDx, Inc.

Media Relations

Anna Czene

818-731-2203

[email protected]

Investor Relations

Caroline Corner

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH SURGERY MANAGED CARE CLINICAL TRIALS GENERAL HEALTH BIOTECHNOLOGY

SOURCE: CareDx, Inc.